Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: A clinicopathologic study of 5 cases

Journal of the Chinese Medical Association

Volumn 70, Issue 12, 2007, Pages 551-555

  Yu, Yuan Bin ^a,b   Li, Chun Yi ^a,b   Chen, Chih Cheng ^c   You, Jie Yu ^a,b   Chau, Wing Keung ^a,b   Hsu, Hui Chi ^a,b   Gau, Jyh Pyng ^a,b   Chen, Po Ming ^a,b   Ho, Chao Hung ^a,b,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Cladribine; Hairy cell leukemia; Splenectomy

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CLADRIBINE;

ADULT; AGED; ARTICLE; BONE MARROW EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOMA; MALE; NEUTROPENIA; PANCYTOPENIA; RETROSPECTIVE STUDY; SIDE EFFECT; SPLEEN; SPLENECTOMY; SPLENOMEGALY; STAINING; TAIWAN; THROMBOCYTE COUNT; TISSUE SECTION; TREATMENT OUTCOME;

EID: 38049129561     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70059-5     Document Type: Article

References (12)

1. Goodman GR, Bethel KJ, Saven A. Hairy cell leukemia: an update. Curr Opin Hematol 2003;10:258-66.
2. Foucar KM, Catovsky D. Hairy cell leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001:138-41.
3. Jansen J, Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 1981;47:2066-76.
4. Spiers AS, Moore D, Cassileth PA, Harrington DP, Cummings FJ, Neiman RS, Bennett JM, et al. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med 1987; 316:825-30.
5. Chadha P, Rademaker AW, Mendiratta P, Kim B, Evanchuk DM, Halkimian D, Peterson LC, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood 2005;106:241-6.
6. Hoffman MA, Janson D, Rose E, Rai KR. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. J Clin Oncol 1997;15:1138-42.
7. Chen LM, Chung YC, Chao TY. Hairy cell leukemia: experience of two cases in Taiwan. J Med Sci 2005;25:157-60.
8. Yang MH, Ho CH. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. J Chin Med Assoc 2001; 64:54-8.
9. Au WY, Kwong YL, Ma SK, Mak YK, Wong KF, Lei KI, Ng MH, et al. Hairy cell leukemia in Hong Kong Chinese: a 12-year retrospective survey. Hematol Oncol 2000;18:155-9.
10. Bernstein L, Newton P, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 1990;50: 3605-9.
11. Wood L, Baker PM, Martindale A, Jacobs P. Splenectomy in haematology: a 5-year single centre experience. Hematology 2005;10:505-9.
12. Flinn IW, Kopecky KJ, Foucar MK, Head D, Bennett JM, Hutchison R, Corbett W, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 2000;96: 2981-6.